Business
Bluebird Bio's Gene Therapy for a Rare Blood Disorder Was Cleared by US Regulators - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Bluebird Bio’s gene therapy for a rare blood disorder was cleared by US regulators ...'
Bluebird Bio’s gene therapy for a rare blood disorder was cleared by US regulators https://t.co/JKMQFZO3At— Bloomberg (@business) August 17, 2022
(The above story first appeared on LatestLY on Aug 18, 2022 01:11 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
